Noninfective chorioretinitis – Diagnostics – Overview of Information and Clinical Research

Noninfective chorioretinitis is an inflammatory condition affecting the back layers of the eye, where the retina and choroid become inflamed without an infectious cause. Because the choroid supplies vital nutrients to the retina, this inflammation can threaten vision if not properly identified and managed. Understanding when and how to seek diagnostic testing is essential for protecting your sight.

Introduction: Who Should Seek Diagnostics

Diagnostic testing for noninfective chorioretinitis is important for anyone experiencing sudden changes in their vision, especially when these changes cannot be explained by common conditions like needing new glasses. If you notice symptoms such as floating black spots or cobweb-like shapes drifting across your field of vision, flashes of light that seem to appear out of nowhere, or a gradual blurring that makes it harder to see clearly, you should schedule an eye examination promptly.^[1]^[2]

People with certain underlying health conditions should be particularly alert to the need for diagnostic testing. If you have been diagnosed with an autoimmune disease—a condition where the body’s immune system mistakenly attacks its own tissues—such as rheumatoid arthritis, sarcoidosis, or Behçet’s disease, you face a higher risk of developing this type of eye inflammation. Similarly, individuals who experience eye pain, redness, sensitivity to bright light, or difficulty seeing colors should not delay seeking medical attention, as these symptoms may indicate active inflammation in the deeper structures of the eye.^[2]^[8]

It is also advisable to undergo regular eye examinations if you have a history of eye trauma or injury, even if the injury occurred years ago. Sometimes inflammation can develop or reactivate long after the initial event. Women of childbearing age appear to be more commonly affected by inflammatory eye conditions than men, so this group should remain vigilant about eye health.^[5]

⚠️ Important

Chorioretinitis is responsible for a significant portion of blindness cases in the United States, contributing to approximately 10% to 15% of all cases of complete blindness. The condition causes around 30,000 new cases of legal blindness each year in the country. Early detection through proper diagnostics can help prevent these severe outcomes.^[5]

Classic Diagnostic Methods

Dilated Eye Examination

The foundation of diagnosing noninfective chorioretinitis is a comprehensive dilated eye examination performed by an eye care provider, typically an ophthalmologist or optometrist. During this examination, special eye drops are placed in your eyes to widen your pupils. This process, called dilation, allows the doctor to see all the way to the back of your eye where the retina and choroid are located. The drops may sting slightly and will cause temporary blurring and light sensitivity that can last several hours, so it is wise to bring sunglasses and arrange for someone to drive you home.^[2]^[8]

Using a specialized microscope called a slit lamp, the doctor focuses a high-powered beam of light into your eye. This allows them to examine the front structures of your eye, including the cornea and the fluid-filled chamber behind it. In cases of chorioretinitis, the doctor may observe cells floating in the vitreous—the clear gel that fills the space between the lens and the retina—which indicates inflammation. The doctor will also use an instrument called an ophthalmoscope to look at your retina and choroid, searching for signs of inflammation, scarring, bleeding, or abnormal patches of tissue or color.^[2]^[15]

Sometimes doctors can identify chorioretinal scars, which are areas of permanent damage that look like patches of altered tissue or color at the back of the eye. These scars provide important clues about whether the inflammation has been present for a long time or has occurred repeatedly in the past.^[2]

Laboratory Testing

While noninfective chorioretinitis is not caused by bacteria, viruses, or parasites, laboratory tests are still essential because they help rule out infectious causes and identify underlying systemic conditions that might be triggering the inflammation. Your doctor may take a small sample of material from your eye using a gentle swabbing technique. This sample is then sent to a laboratory where specialists test it to ensure no infection is present.^[2]^[8]

Blood tests are commonly ordered to look for markers of autoimmune diseases. For example, doctors may test for antibodies associated with sarcoidosis, a disease that causes inflammation in various body tissues, or Behçet’s disease, which causes blood vessel inflammation. These blood tests help doctors understand whether the eye inflammation is part of a broader disease affecting multiple organs in your body. In some cases, additional tests may be needed to rule out conditions like tuberculosis or syphilis, even though these are infectious causes, as it is important to be absolutely certain about the underlying cause before starting treatment.^[2]^[4]

Optical Coherence Tomography (OCT)

Optical coherence tomography, usually called OCT, is a sophisticated imaging test that uses reflected light to create detailed cross-sectional pictures of the back of your eye. Think of it as similar to an ultrasound, but using light waves instead of sound waves. The test is completely painless and noninvasive—you simply rest your chin on a support and look at a target while a scanning device moves around your eye. The entire process takes only a few minutes.^[2]^[8]

OCT provides incredibly detailed images that show the individual layers of your retina, almost like looking at a slice through a layer cake. This allows your doctor to see swelling, fluid accumulation, or structural damage caused by inflammation. The test is especially useful for monitoring how well treatment is working, as it can detect even small changes in the thickness or structure of the retinal layers over time.^[2]

Fluorescein Angiography

Fluorescein angiography is a specialized imaging test that allows your doctor to see the blood vessels at the back of your eye in great detail. Before the test begins, a small amount of a yellow-orange dye called fluorescein is injected into a vein in your arm. This dye travels through your bloodstream and reaches the blood vessels in your eyes within seconds. As the dye circulates through the vessels in your retina and choroid, a special camera takes rapid-sequence photographs. The dye causes the blood vessels to glow brightly in these images, making it easy to see any areas where vessels are leaking, blocked, or growing abnormally.^[2]^[8]

Some people experience mild nausea during the injection, and your skin may temporarily have a slight yellowish tinge. Your urine will turn bright orange or yellow for a day or two after the test, which is completely normal and harmless. The test is particularly valuable for identifying the characteristic patterns of blood vessel damage that occur in different types of chorioretinitis.^[2]

Indocyanine Green (ICG) Angiography

Indocyanine green angiography, or ICG angiography, works on a similar principle to fluorescein angiography but uses a different dye that is particularly good at highlighting the choroid—the layer of blood vessels beneath the retina. Because the choroid has a rich network of blood vessels and is the primary structure affected in chorioretinitis, this test provides crucial information that fluorescein angiography might miss. The dye is injected into your arm just like with fluorescein angiography, and photographs are taken as it circulates through your eye.^[2]^[8]

ICG angiography is especially valuable because it can reveal inflammation and damage in the choroid that cannot be seen with ordinary examination or even with other imaging techniques. This makes it an important tool for diagnosing certain forms of noninfective chorioretinitis and for monitoring how the inflammation responds to treatment over time.^[2]

Additional Imaging Studies

In some cases, your doctor may order additional imaging tests to get a complete picture of the inflammation. Ultrasound of the eye uses sound waves to create images and can be helpful when the view to the back of the eye is blocked by clouding in the vitreous or other structures. This test is particularly useful for distinguishing chorioretinitis from other conditions that may cause similar symptoms, such as posterior scleritis, which is inflammation of the white outer coat of the eye. In posterior scleritis, ultrasound typically shows fluid accumulation beneath a specific layer that creates a characteristic appearance called the “T sign.”^[1]^[4]

⚠️ Important

When left untreated, chorioretinitis can lead to permanent vision loss. The inflammation can cause scarring of the retina and choroid, which irreversibly damages the light-sensing cells needed for vision. This is why prompt diagnosis and treatment are critical for preserving your eyesight.^[2]^[8]

Diagnostics for Clinical Trial Qualification

If you are considering participating in a clinical trial for noninfective chorioretinitis, you will need to undergo additional diagnostic testing beyond what is typically required for standard clinical care. Clinical trials have strict criteria to ensure that participants have a confirmed diagnosis and that researchers can accurately measure whether the treatment being studied is effective. These qualification criteria, called inclusion and exclusion criteria, help protect your safety and ensure the scientific validity of the study results.^[9]

Most clinical trials for noninfective chorioretinitis require comprehensive baseline documentation of your eye condition before treatment begins. This typically includes all of the standard diagnostic tests described earlier—dilated eye examination, OCT imaging, and angiography studies—but performed according to specific protocols that may be more detailed or frequent than in routine care. These baseline measurements establish a starting point that researchers will use to determine whether the treatment causes improvement, stabilization, or worsening of your condition over time.^[9]

Specialized Imaging for Trial Monitoring

Clinical trials often use advanced imaging techniques to monitor the inflammation with great precision. Indocyanine green angiography is particularly important in trials because it is currently the most reliable way to directly visualize inflammation in the choroid. Researchers have found that ICGA can show areas of active inflammation that may not be visible with other imaging methods. This makes it an essential tool for determining whether a treatment is actually controlling the underlying disease process, not just suppressing symptoms.^[11]

In clinical trials studying severe forms of noninfective choroiditis, such as serpiginous choroiditis or multifocal choroiditis, ICGA is used repeatedly throughout the study to track changes in the inflammation. Researchers look for specific findings, such as hyperfluorescent spots (areas that appear brighter due to inflammation) or areas of nonperfusion (where blood flow has stopped due to damage). The reduction or resolution of these abnormalities indicates that the treatment is working.^[11]

Visual Function Testing

Clinical trials measure not only whether the inflammation improves but also whether your vision improves or is preserved. Standard visual acuity testing—where you read letters on a chart—is performed at every visit using standardized protocols that are more rigorous than in typical eye exams. Researchers need these measurements to be extremely consistent and reproducible so they can detect even small changes in your vision over time.^[11]

Visual field testing is another important component of clinical trial diagnostics. This test maps your peripheral vision—your ability to see objects to the side while looking straight ahead. In chorioretinitis, inflammation or scarring can create blind spots or areas of reduced sensitivity in your visual field. By repeating this test throughout the trial, researchers can determine whether the treatment prevents vision loss or allows recovery of areas that were previously affected.^[11]

Laboratory Monitoring for Safety

Because many treatments for noninfective chorioretinitis, particularly those used in clinical trials, can affect the immune system or other body systems, extensive laboratory testing is required to monitor for side effects. Blood tests are performed regularly to check your liver function, kidney function, blood cell counts, and immune system activity. These tests ensure that the treatment is not causing harmful effects on other organs while it controls the eye inflammation.^[9]

Some trials may require additional specialized blood tests to measure the levels of inflammatory markers—substances in your blood that indicate how active the inflammation is throughout your body. These markers can provide additional evidence about whether the treatment is working, especially for noninfective chorioretinitis associated with systemic autoimmune diseases.^[9]

Prognosis and Survival Rate

Prognosis

The outlook for people with noninfective chorioretinitis depends heavily on several factors, including how quickly the condition is diagnosed, which specific type of chorioretinitis is present, whether it is associated with a systemic autoimmune disease, and how well the inflammation responds to treatment. When diagnosed early and treated promptly with appropriate medications, many people can preserve good vision and prevent serious complications.^[2]^[8]

However, certain forms of noninfective chorioretinitis, particularly serpiginous choroiditis, can be quite aggressive. Serpiginous choroiditis has been described as the most aggressive form of inflammation affecting the tiny blood vessels in the choroid. Without diligent management using multiple immunosuppressive medications, this type can result in extensive scarring that permanently damages vision. Research has shown that early treatment with combinations of steroids and other immunosuppressive drugs can substantially reduce the progression of scarring and help preserve visual function.^[11]

The risk of recurrence varies depending on the underlying cause and type of chorioretinitis. Some forms, such as those associated with certain autoimmune diseases, tend to have a chronic pattern with periods of active inflammation alternating with periods of quiet. This means that even after successful initial treatment, ongoing monitoring and sometimes long-term maintenance therapy may be necessary to prevent flare-ups that could threaten vision.^[9]

Factors that influence prognosis include the location of the inflammation within the eye—inflammation affecting the central part of the retina called the macula typically has a greater impact on vision than inflammation in the peripheral areas. The presence of complications such as abnormal blood vessel growth, fluid accumulation under the retina, or scarring also worsens the outlook. Additionally, people whose chorioretinitis is part of a broader systemic disease may face additional challenges in managing both their eye condition and their overall health.^[11]

Survival rate

Noninfective chorioretinitis is not a life-threatening condition, and there is no mortality directly associated with the eye disease itself. However, the condition can have a profound impact on quality of life due to vision loss. Studies have shown that chorioretinitis and related forms of uveitis are responsible for approximately 2.8% to 10% of all cases of blindness in the United States. The condition causes around 30,000 new cases of legal blindness each year, contributing to 10% to 15% of all instances of complete blindness in the nation.^[5]^[17]

While these statistics might seem concerning, it is important to understand that they reflect outcomes across all cases, including those that were diagnosed late, did not receive adequate treatment, or involved particularly aggressive forms of the disease. With modern diagnostic techniques and treatment options, many people with noninfective chorioretinitis can maintain functional vision and continue their normal activities. The key to achieving the best possible outcome is seeking medical attention as soon as symptoms appear and following through with recommended treatment and monitoring plans.^[2]

#1 Clinical Trials Search in Europe